NEWS: JULY 2005

-07/22/2005-

Press Release: Radleys (Saffron Walden, UK) have introduced a revolutionary new Calorimetry module for their Lara Controlled Laboratory Reactor (CLR) system that sets new standards in accuracy, repeatability, operational flexibility and ease-of-use. To read press release click here.

Gilead Sciences Inc. and Royalty Pharma purchase the royalty interest owed to Emory University for emtricitabine. To read article click here.

Schering-Plough to acquire rights for INTEGRILIN® (eptifibatide) injection from Millennium. To read article click here.

Scientists at Galileo Pharmaceuticals Inc. confirm direct relationship between inflammation and glucose levels. To read article click here.

Adolor Corporation receives FDA's approvable letter for Entereg® (alvimopan) capsules. To read article click here.

-07/21/2005-

Alexza MDC changes name to Alexza Pharmaceuticals. To read article click here.

Researchers at Introgen Therapeutics Inc. and The University of Texas M. D. Anderson Cancer Center publish in the Journal of Leukocyte Biology the role of IL-24 in regulating the immune system and cancer inhibition. To read article click here.

Nabi Biopharmaceuticals begins Phase I clinical trials of Staphylococcus aureus Type 336 vaccine. To read article click here.

Pfizer Inc. to cut jobs. To read article click here.

ChemDiv Inc. and Scripps Florida extend compound-library collaboration. To read article click here.

MGI Pharma Inc. acquires Guilford Pharmaceuticals Inc. To read article click here.

-07/20/2005-

Press Release: Manufactured from ultra-pure grade polypropylene, the new 24-well Deep-well plate from Porvair Sciences Ltd. has near zero leachates making it an ideal long-term sample storage medium. To read press release click here.

Chiron Corp. will supply any Begrivac flu virus vaccine doses to non-U.S. markets. To read article click here.

Scios Inc. receives subpoena over drug Natrecor (Nesiritide). To read article click here.

-07/19/2005-

Press Release: A research journal article* written by scientists at Wyle Laboratories and NASA's Johnson Space Center, both in Houston, USA and published in Cytometry Part B (Clinical Cytometry), describes how Guava Technologies' novel flow cytometric technology offers the potential for spaceflight-compatible readings. To read press release click here.

Cephalon Inc. completes acquisition of TRISENOX® from Cell Therapeutics Inc. To read article click here.

Corixa Corp. cuts 70 jobs at its Seattle offices. To read article click here.

Eli Lilly & Co. and Alkermes Inc. begins Phase 3 clinical trials of inhaled insulin system. To read article click here.

-07/18/2005-

Geron Corp. and Merck & Co. sign collaboration agreement for the development of a cancer vaccine against telomerase. To read article click here.

Sankyo Co. Ltd. and Metabasis Therapeutics Inc. to resume development of CS-917 for type 2 diabetes. To read article click here.

-07/14/2005-

Nation's first Vioxx trial begins. To read article click here.

-07/13/2005-

Press Release: The MaxiLute™ solid phase extraction microplate system from Porvair Sciences offers unmatched optimised processing of drug development, food and environmental samples. To read press release click here.

Press Release: A new version of the popular HT-12 Series II system from Genevac has been introduced to provide laboratories with a highly efficient and safe means of routinely removing strongly acidic chemicals from their samples. To read press release click here.

-07/11/2005-

Press Release: INTEGRA Biosciences has announced a new applications study, undertaken in conjunction with CEPower GmbH (Wadenswil, Switzerland), describing the advantages of a novel disposable flask bioreactor for cultivation of high levels of recombinant proteins in CHO cells. To read press release click here.

-07/07/2005-

Press Release: Using a range of scientific equipment supplied by Radleys the development kitchen at the Fat Duck Restaurant (Bray, UK), owned by the world's No. 1 chef Heston Blumenthal, is undertaking research to produce novel food textures and innovative food for high-end gastronomy. To read press release click here.

-07/05/2005-

Press Release: Barnstead Genevac has announced that it will show its latest innovative products optimising drug discovery and development at the forthcoming Drug Discovery Technology® & Development World Congress 2005 in Boston, USA. To read press release click here.

-07/04/2005-

Press Release: Guava Technologies have introduced, for scientists in drug discovery and oncology research, four new options for assessing cellular function including mitochondrial membrane potential, cellular proliferation, and activation of caspase 3/7 or 8 enzymes. To read press release click here.